About Laverock Therapeutics

Laverock Therapeutics develops programmable cell and gene therapies using a platform that controls gene expression with precision. The technology enables cells to respond intelligently to disease, activating therapeutic effects only where and when needed. This approach addresses critical challenges in advanced therapies by creating treatments that work with the body's natural systems. The platform combines gene silencing, automated cell engineering and rapid genotyping to deliver disease responsive, highly effective therapies with improved safety profiles. Patients with cancer and genetic diseases benefit from treatments that adapt dynamically to their condition, offering new hope where standard therapies fall short.